|
|
When searching for a medical marijuana lawyer in Colorado, you should be very selective. Having the right attorneys, with the right set of business, real estate, corporate, criminal defense, trial, and constitutional skills can mean the world. The consequences are serious. The law in this area is complex and difficult to navigate on your own. Our law firm has a team of lawyers, some with more than 30+ years of experience, who are experienced not just in medical marijuana, but in business law, real estate law, and criminal defense. We work as a team to acheive your goals. Our law firm stands out because it can provide you with all the services you need to set up shop, incorporate, or get licensed. These are the services our our law firm can provide to you:
- Licensing
-
Patients
- Centers
- Infused Products
- Optional Site Grow
- Forming Corporations
- LLC's
- Operating Agreements
- State & Federal Filing
- EIN's & Accounts
- Sale & Transfer of Company
- Contract Reviews
- Business Plans & Layouts
- Inventory
-
Signage
- Security
- Accounting
|
- Commercial Lease's
- Real Estate Purchase Agreements
- Legal Compliance Checks
- State Laws
- County Laws
- City Laws & Ordinances
- Zoning
- Building Codes
- Tax Planning
- Growing Contracts
- Center to Center Contracts
- Criminal Defense & Trials
- Appeals
- And more.....
|
About Medical Marijuana (Cannibus): Medical marijuana (also referred to as medical marijuana) refers to the use of Cannabis (marijuana), including constituents of marijuana, THC and other cannabinoids, as a physician-recommended form of medicine or herbal therapy. Cannabis has a long history of medicinal use, with evidence dating back to 2,000 B.C.E. Although the extent of the medicinal value of marijuana has been debated, it does have several well-documented beneficial effects. Among these are: the amelioration of nausea and vomiting, stimulation of hunger in chemotherapy and AIDS patients, lowered intraocular eye pressure (shown to be effective for treating glaucoma), as well as general analgesic effects (pain reliever). Less confirmed individual studies also have been conducted indicating marijuana is beneficial in a variety of conditions including Multiple sclerosis and depression. Synthetic cannabinoids are also available as prescription drugs in many countries. Examples include Marinol, available in Germany and the United States, and Cesamet, available in Canada, Mexico, the United Kingdom, and also in the United States. There are several methods for administration of dosage, including vaporizing or smoking dried buds, drinking or eating extracts, and taking capsules.[6][7] The comparable efficacy of these methods was the subject of an investigative study [5] conducted by the National Institutes of Health. While marijuana for recreational use is illegal in most parts of the world, its use as a medicine is legal in a number of territories worldwide, including Canada, Austria, Germany, the Netherlands, Spain, Israel, Italy, Finland, and Portugal. In the United States, federal law outlaws all marijuana use, while permission for medical marijuana varies among states. Distribution is usually done within a framework defined by local laws. Medical marijuana remains a controversial issue worldwide.
In a 2002 review of medical literature, medical marijuana was shown to have established effects in the treatment of nausea, vomiting, premenstrual syndrome, unintentional weight loss, and lack of appetite. Other "relatively well-confirmed" effects were in the treatment of "spasticity, painful conditions, especially neurogenic pain, movement disorders, asthma, and glaucoma". Preliminary findings indicate that marijuana-based drugs could prove useful in treating inflammatory bowel disease (consisting of Crohn's disease and ulcerative colitis), migraines, fibromyalgia, and related conditions. Medical marijuana has also been found to relieve certain symptoms of multiple sclerosis and spinal cord injuries by exhibiting antispasmodic and muscle-relaxant properties as well as stimulating appetite. Clinical trials provide evidence that THC reduces motor and vocal tics of Tourette syndrome and related behavioral problems such as obsessive–compulsive disorders. Other studies have shown marijuana or cannabinoids may be useful in treating alcohol abuse, attention-deficit hyperactivity disorder (ADHD or AD/HD) amyotrophic lateral sclerosis, collagen-induced arthritis, rheumatoid arthritis, asthma, atherosclerosis, autism, bipolar disorder, childhood mental disorders, colorectal cancer,] depression, diabetic retinopathy, dystonia, epilepsy, digestive diseases, gliomas, hepatitis C, Huntington's disease,] hypertension, urinary incontinence, leukemia, skin tumors, morning sickness, methicillin-resistant Staphylococcus aureus (MRSA), Parkinson's disease, pruritus, posttraumatic stress disorder (PTSD), sickle-cell disease, sleep apnea, tourette syndrome, and anorexia nervosa.
In the United States, it is important to differentiate between medical marijuana at the federal and at the state level. At the federal level, marijuana per se has been made criminal by implementation of the Controlled Substances Act which classifies marijuana as a Schedule I drug, the strictest classification on par with heroin, LSD and Ecstasy, and the Supreme Court ruled in 2005 that the Commerce Clause of the U.S. Constitution allowed the government to ban the use of marijuana, including medical use. The United States Food and Drug Administration states "marijuana has a high potential for abuse, has no currently accepted medical use in treatment in the United States, and has a lack of accepted safety for use under medical supervision". On the state level, 14 states have legalized medical marijuana: Alaska, California, Colorado, Hawaii, Maine, Michigan, Montana, Nevada, New Jersey, New Mexico, Oregon, Rhode Island, Vermont and Washington Maryland allows for reduced penalties if marijuana use has a medical basis.] California, Colorado, New Mexico, Maine, Rhode Island, and Montana are currently the only states to utilize dispensaries to sell medical marijuana. California's medical marijuana industry took in about $2 billion a year and generated $100 million in state sales taxes during 2008 with an estimated 2,100 dispensaries, co-operatives, wellness clinics and taxi delivery services in the sector colloquially known as “cannabusiness”. New Jersey has recently passed a bill legalizing marijuana for medicinal purposes. On 19 October 2009 the US Deputy Attorney General issued a US Department of Justice memorandum to "All United States Attorneys" providing clear clarification and guidance to federal prosecutors in US States that have enacted laws authorizing the medical use of marijuana. The document is intended solely as "a guide to the exercise of investigative and prosecutorial discretion and as guidance on resource allocation and federal priorities." The US Deputy Attorney General David W. Ogden provided seven criteria, the application of which acts as a guideline to prosecutors and federal agents to ascertain whether a patients use, or their caregivers provision, of medical marijuana "represents part of a recommended treatment regiment consistent with applicable state law", and recommends against prosecuting patients using medical marijuana products according to state laws. Not applying those criteria, the Dep. Attorney General Ogden concludes, would likely be "an inefficient use of limited federal resources". The memorandum does not change any laws. Sale of marijuana remains illegal under federal law unless there is a very rare permission. The U.S. Food and Drug Administration's position, that marijuana has no accepted value in the treatment of any disease in the United States, has also remained the same. Nevertheless, the memorandum is seen by some United States commentators to be the first step in which President Obama's Administration may come good on its pre-election promise to address the issue of medical marijuana in federal policymaking. The Health and Human Services Division of the federal government holds a patent for medical marijuana. The patent, "Cannabinoids as antioxidants and neuroprotectants", issued October 2003[140] reads: "Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia…"
Credit for this article is due to Wikipedia, and sources cited within. |
|